Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
With Afrezza now approved for use in children, Mankind believes it finally has the push…
ASCO: After Takeda loss, Dizal picks up the baton and takes on J&J in EGFR lung cancer subtype
Editor’s note: This article will be updated after the study is published Friday afternoon. Please…
Japan’s prime minister’s meeting becomes even more hawkish on biotechnology – Fierce Pharma Asia
As Chinese development assets gain attention from biopharmaceutical traders, some industry watchers want to curb…
Branded drug prices rise after launch in the US, fall overseas due to MFN push: Report
A report from the AARP Public Policy Institute released Thursday found that many top-brand drugs…
AstraZeneca fires another salvo in its bladder cancer race with Merck’s Keytruda, with the FDA…
Top pharmaceutical industry leaders meet with Prime Minister Takaichi to encourage Japan to maintain its R&D advantage
Amid China’s growing dominance in biopharmaceutical research and development, global pharmaceutical leaders visited neighboring Japan…
CVS Caremark, the nation’s top pharmacy benefit manager (PBM), will reinstate coverage for Eli Lilly’s…
PharmaEssentia has hired Eric Vogel as its new head of U.S. commercialization as it looks…
As AbbVie continues to leverage its deal with Immunogen to grow its commercially available antibody-drug…
Kaleo has launched the AUVI-Q Speaks Up campaign to share the stories of patients, caregivers…